Literature DB >> 18525277

Integrase polymorphism and HIV-1 group O diversity.

Marie Leoz, Agnès Depatureaux, Aurélia Vessière, Bénédicte Roquebert, Florence Damond, Dominique Rousset, Pierre Roques, François Simon, Jean-Christophe Plantier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18525277     DOI： 10.1097/QAD.0b013e3283021c30

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.

Authors:  Mohan Kumar Haleyur Giri Setty; Jikun Liu; Prerna Mahtani; Panhe Zhang; Bingchen Du; Viswanath Ragupathy; Krishnakumar Devadas; Indira K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

Review 2.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection.

Authors:  Marie Gueudin; Marie Leoz; Véronique Lemée; Fabienne De Oliveira; Aurélia Vessière; Anfumbom Kfutwah; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

4.  HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integrase.

Authors:  Agnès Depatureaux; Peter K Quashie; Thibault Mesplède; Yingshan Han; Hannah Koubi; Jean-Christophe Plantier; Maureen Oliveira; Daniela Moisi; Bluma Brenner; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

5.  Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy.

Authors:  Charlotte Charpentier; Laurence Weiss
Journal:  Infect Drug Resist       Date:  2010-10-13       Impact factor: 4.003

6.  The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.

Authors:  Marie Leoz; Felix Feyertag; Anfumbom Kfutwah; Philippe Mauclère; Guillaume Lachenal; Florence Damond; Fabienne De Oliveira; Véronique Lemée; François Simon; David L Robertson; Jean-Christophe Plantier
Journal:  PLoS Pathog       Date:  2015-08-04       Impact factor: 6.823
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.